Advertisement
Advertisement
BAX
Baxter International Inc.
16.75
USDSponsored
+0.13
+0.78%
May 05, 15:59 UTC -4
Closed
After-Market
16.77
+0.02
+0.12%
BAX Earnings Reports
Positive Surprise Ratio
BAX beat 33 of 41 last estimates.
80%
Next Report
Date of Next Report
Jul 29, 2026
Estimate for Q2 26 (Revenue/ EPS)
$2.83B
/$0.38
Implied change from Q1 26 (Revenue/ EPS)
+4.69%
/+5.56%
Implied change from Q2 25 (Revenue/ EPS)
+0.63%
/-35.59%
Baxter International Inc. earnings per share and revenue
On Apr 30, 2026, BAX reported earnings of 0.36 USD per share (EPS) for Q1 26, beating the estimate of 0.31 USD, resulting in a 15.87% surprise. Revenue reached 2.70 billion, compared to an expected 2.64 billion, with a 2.24% difference. The market reacted with a +4.02% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 11 analysts forecast an EPS of 0.38 USD, with revenue projected to reach 2.83 billion USD, implying an increase of 5.56% EPS, and increase of 4.69% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Bio-Rad Laboratories, Inc.Class A
Report Date
Apr 30, 2026 For Q1 26
Estimate
$2.00
Actual
$1.89
Surprise
-5.68%
LeMaitre Vascular, Inc.
Report Date
May 05, 2026 For Q1 26
Estimate
$0.67
Actual
$0.68
Surprise
+0.86%
Stryker Corporation
Report Date
Apr 30, 2026 For Q1 26
Estimate
$3.01
Actual
$2.60
Surprise
-13.75%
ResMed Inc.
Report Date
Apr 30, 2026 For Q3 26
Estimate
$2.82
Actual
$2.86
Surprise
+1.28%
AdaptHealth Corp. Common Stock
Report Date
May 05, 2026 For Q1 26
Estimate
$0.01
Actual
-$0.06
Surprise
-442.86%
AtriCure, Inc.
Report Date
May 05, 2026 For Q1 26
Estimate
-$0.06
Actual
$0.00
Surprise
+100.00%
QuidelOrtho Corporation Common Stock
Report Date
May 05, 2026 For Q1 26
Estimate
$0.40
Actual
-$0.04
Surprise
-109.93%
Cerus Corp
Report Date
Apr 30, 2026 For Q1 26
Estimate
-$0.04
Actual
-$0.01
Surprise
+75.49%
Viemed Healthcare, Inc. Common Shares
Report Date
May 05, 2026 For Q1 26
Estimate
$0.09
Actual
$0.06
Surprise
-33.99%
Evolus, Inc. Common Stock
Report Date
May 04, 2026 For Q1 26
Estimate
-$0.13
Actual
-$0.10
Surprise
+24.59%
FAQ
What were Baxter International Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Baxter International Inc. reported EPS of $0.36, beating estimates by 15.87%, and revenue of $2.70B, 2.24% above expectations.
How did the market react to Baxter International Inc.'s Q1 2026 earnings?
The stock price moved up 4.02%, changed from $16.90 before the earnings release to $17.58 the day after.
When is Baxter International Inc. expected to report next?
The next earning report is scheduled for Jul 29, 2026.
What are the forecasts for Baxter International Inc.'s next earnings report?
Based on 11
analysts, Baxter International Inc. is expected to report EPS of $0.38 and revenue of $2.83B for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement